Skip to main content
Clinical Trials/NCT04647630
NCT04647630
Recruiting
Not Applicable

Prospective Study to Evaluate Streptococcus Pneumoniae Serotypes Prevalence in Community Acquired Pneumonia in Hong Kong Using a Urinary Kit

Chinese University of Hong Kong1 site in 1 country1,800 target enrollmentJanuary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Community-acquired Pneumonia
Sponsor
Chinese University of Hong Kong
Enrollment
1800
Locations
1
Primary Endpoint
Determine the prevalence of pneumococcal serotypes in adults hospitalized
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This is an epidemiology study for the prevalence and serotypes of pneumococcus pneumoniae in hospitalized patients with community acquired pneumonia (CAP). The serotypes of the pneumococcus pneumoniae will be determined by a urinary antigen assay. This is a single center, non-interventional observatory study.

Detailed Description

Patients admitted to the medical wards with a provisional diagnosis under "pneumonia","chest infection" or "fever" will be screened by research assistants. Patients eligible with the inclusion criteria will be recruited into the study. Informed consent will be signed for those patients willing to participate in the study. Patient will be asked to save approximately 40 ml of urine. The urine sample will be processed in local laboratory and shipped out to a commercial lab for detection of any pneumococcal pneumoniae, and if present, serotyping will be performed at the same time using the same urine sample by urinary antigen assay. Meanwhile patients will be managed as usual by their clinical teams. Investigations and treatment will be offered by the clinical team as deemed necessary. The study team will only perform collection of urine and will not interfere the clinical management of the patients. Positive results would be informed to the clinical teams for the appropriate action.

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
December 31, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

To Kin Wang

Honoary Clinical Associate Professor

Chinese University of Hong Kong

Eligibility Criteria

Inclusion Criteria

  • Admitted with signs and symptoms suggestive of pneumonia

Exclusion Criteria

  • Nosocomial pneumonia which is acquired \>= 48 hours after hospital admission.
  • Pneumonia which are already known to be caused by pathogens other than pneumococcus pneumoniae.

Outcomes

Primary Outcomes

Determine the prevalence of pneumococcal serotypes in adults hospitalized

Time Frame: 2 years

Determine the prevalence of pneumococcal serotypes in adults hospitalized with pneumococcal community acquired pneumonia (CAP) using a specific urine antigen assay

Study Sites (1)

Loading locations...

Similar Trials